D.E. Shaw & Co

D.E. Shaw & Co’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

D.E. Shaw & Co’s Portfolio NBSE Stock Details NBSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell
2022 Q1	$70K	Buy
2021 Q4	–	Sell
2021 Q3	$162K	Sell
2021 Q2	$278K	Sell
2021 Q1	$711K	Buy
2020 Q4	$288K	Buy
2016 Q2	–	Sell
2016 Q1	$167K	Buy